Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-26-119153·Sealbond Ltd
Schedule 13D ownership disclosure
DOGWOOD THERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 92829J203
Event date: 2026-10-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sealbond LimitedReported CIK 0002040446
Shares: 25,920,693.00 · Class: 67.8%
- CK Life Sciences Int'l., (Holdings) Inc.
Shares: 28,763,331.00 · Class: 75.2%
- Conjoint Inc.
Shares: 2,842,638.00 · Class: 7.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-119153
- Form type
- SCHEDULE 13D/A
- Filer
- Sealbond Ltd
- CIK
- CIK 2040446
- Filed
- Oct 27, 2026
- Reporting period
- Oct 26, 2026
- Description
- Schedule 13D beneficial ownership